Robertson Stephens Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Robertson Stephens Wealth Management, LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $20.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$20.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 164,166 | $9.1M |
| GILDGILEAD SCIENCES, INC. | 52,618 | $7.3M |
| ADPTAdaptive Biotechnologies Corp | 97,218 | $1.3M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,836 | $938K |
| MRNAModerna, Inc. | 14,855 | $755K |
| INCYIncyte Corp. | 6,683 | $629K |
| RLMDRELMADA THERAPEUTICS, INC. | 25,000 | $174K |
| CUECue Biopharma, Inc. | 478,500 | $110K |
| ATAIAtai Beckley N.V. | 28,297 | $100K |
| ANVSAnnovis Bio, Inc. | 18,579 | $41K |
| ANIXAnixa Biosciences Inc | 15,649 | $40K |
| CGTXCOGNITION THERAPEUTICS INC | 10,000 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.